April 13, 2018 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb’s oncology portfolio. The companies plan to develop a diagnostic version of the Illumina TruSight Oncology... Read more

April 12, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships Product Launch

St. Jude Cloud, largest public repository of pediatric cancer genomics data, launches for researchers worldwide

St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases.   Memphis, Tennessee, April 12, 2018 St. Jude Children’s Research Hospital today launched St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world’s largest... Read more

April 12, 2018 Clinical Research/Diagn. Life Science Tools

Hitachi High-Technologies Capital Partitipation in OmniSeq® Offering Molecular Diagnostic Laboratory Services

Tokyo, Japan, April 12, 2018 – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare... Read more

April 12, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 Life Science Tools PR/Corporate

Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR

Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR Company announces next generation Arcturus Cellect LCM System and Oncomine Knowledgebase Reporter update; Scientific presentations to highlight Oncomine assays for tumor mutation load and immune repertoire analysis CARLSBAD, Calif., April 12, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, will... Read more

April 11, 2018 Clinical Research/Diagn. Life Science Tools

Precipio Launches ICE COLD-PCR(TM) Research Access Program for Cancer Centers

COMPLIMENTARY PRECIPIO ICE COLD PCR™  KITS NOW AVAILABLE TO ADVANCE BODY OF RESEARCH AND ACCELERATE MARKET EXPANSION NEW HAVEN, Conn., April 11, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today the launch of its program to provide complimentary ICE COLD-PCR (ICP) kits to cancer researchers studying the field of liquid biopsy. The program... Read more

April 11, 2018 Clinical Research/Diagn. Life Science Tools

HudsonAlpha Using PacBio Sequencing for Childhood Developmental Disabilities Research

MENLO PARK, Calif., April 11, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the HudsonAlpha Institute for Biotechnology is using the organization’s newest Sequel® Sequencing System to support the goal of dramatically increasing the diagnostic success rate in challenging pediatric clinical cases. Led by... Read more

April 10, 2018 Clinical Research/Diagn. Mass Spectrometry Product Launch

SCIEX launches the Citrine™ Triple Quad™ MS/MS Systems in Europe, bringing maximal speed and sensitivity to clinical diagnostics testing

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing April 10, 2018 Darmstadt, Germany — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, is launching the Citrine™... Read more

April 10, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

SAN DIEGO & STAMFORD, Conn.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) today announced a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling, resulting in a distributable, next-generation sequencing (NGS) based companion diagnostic (CDx) with a pan-cancer indication. The co-development partnership will seek approval for a version... Read more

April 10, 2018 Clinical Research/Diagn. Lab Top-10 Product Launch

New SPE Solution Streamlines Urine Drug Testing Workflow

Torrance, Calif. (April 10, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Strata®-X-Drug B Plus – a solid phase extraction (SPE) sample preparation product for urine drug testing in clinical and forensic toxicology labs. An expansion of Phenomenex’s drug testing product line, the new Drug B Plus... Read more

April 5, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 Product Launch

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy OAKWOOD VILLAGE, Ohio, April 5, 2018 /PRNewswire/ — The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates, expanding antimicrobial... Read more